These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30243313)

  • 1. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
    Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
    Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
    Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
    Martin P; Awan AA; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Jadoul M
    Kidney Int; 2022 Dec; 102(6):1228-1237. PubMed ID: 36411019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
    Gordon CE; Balk EM; Francis JM
    Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
    Gordon CE; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Earley A; Di M; Cheung M; Jadoul M; Martin P
    Ann Intern Med; 2019 Oct; 171(7):496-504. PubMed ID: 31546256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
    Awan AA; Jadoul M; Martin P
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
    Awan AAY; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Martin P; Jadoul M
    Ann Intern Med; 2023 Dec; 176(12):1648-1655. PubMed ID: 38079642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.
    Gordon CE; Adam GP; Jadoul M; Martin P; Balk EM
    Am J Kidney Dis; 2023 Oct; 82(4):410-418. PubMed ID: 37061019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
    Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
    Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
    Jadoul M; Martin P
    Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatitis C in patients with chronic kidney disease.
    Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
    World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
    Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
    Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection and chronic renal disease: A review.
    Goel A; Bhadauria DS; Aggarwal R
    Indian J Gastroenterol; 2018 Nov; 37(6):492-503. PubMed ID: 30560540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
    Fabrizi F; Lampertico P; Messa P
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus and chronic progressive kidney disease].
    Kes P; Slavicek J
    Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.
    Constancio NS; Ferraz MLG; Martins CTB; Kraychete AC; Bitencourt PL; Nascimento MMD
    J Bras Nefrol; 2019; 41(4):539-549. PubMed ID: 30806444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
    J Nephrol; 2018 Oct; 31(5):685-712. PubMed ID: 30255440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.